Sarepta Therapeutics (SRPT) Interest & Investment Income (2012 - 2025)
Sarepta Therapeutics (SRPT) posted quarterly Interest & Investment Income of $271000.0 for Q3 2025, down 91.73% year-over-year from $3.3 million in Q3 2024, and up 418.82% quarter-over-quarter from -$85000.0 in Q2 2025.
Powered by 
Analysis
Sarepta Therapeutics (SRPT) Interest & Investment Income (2012 - 2025) Analysis & Trends
Sarepta Therapeutics' Interest & Investment Income history runs 13 years deep, the most recent figure standing at $271000.0 for Q3 2025.
- In Q3 2025, Interest & Investment Income fell 91.73% year-over-year to $271000.0; the TTM figure through Sep 2025 stood at $3.1 million (down 91.46% YoY), while the FY2023 annual figure was $36.3 million, up 2305.41% from the prior year.
- Interest & Investment Income for Q3 2025 stood at $271000.0, up from -$85000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $35.2 million in Q4 2023, with the low at -$1.6 million in Q1 2024.
- The 5-year median for Interest & Investment Income is $271000.0 (2025), against an average of $2.8 million.
- The sharpest annual moves came in 2022 and 2024: Interest & Investment Income jumped 4532.69% in 2022, then slumped 229.24% in 2024.
- Sarepta Therapeutics' Interest & Investment Income stood at $377000.0 in 2021, then soared by 308.75% to $1.5 million in 2022, then surged by 2186.24% to $35.2 million in 2023, then slumped by 90.7% to $3.3 million in 2024, then tumbled by 91.73% to $271000.0 in 2025.
- Business Quant data shows SRPT's Interest & Investment Income at $271000.0 in Q3 2025, -$85000.0 in Q2 2025, and $3.3 million in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Sarepta Therapeutics | 2.36 Bn | 1.57 Bn | 251.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 271,000.00 |
| Jun 30, 2025 | -85,000.00 |
| Sep 30, 2024 | 3.28 Mn |
| Jun 30, 2024 | -339,000.00 |
| Mar 31, 2024 | -1.61 Mn |
| Dec 31, 2023 | 35.23 Mn |
| Sep 30, 2023 | 417,000.00 |
| Jun 30, 2023 | -636,000.00 |
| Mar 31, 2023 | 1.25 Mn |
| Dec 31, 2022 | 9.13 Mn |
| Sep 30, 2022 | 4.78 Mn |
| Jun 30, 2022 | 2.41 Mn |
| Mar 31, 2022 | -286,000.00 |
| Dec 31, 2021 | 95,000.00 |
| Sep 30, 2021 | 148,000.00 |
| Jun 30, 2021 | 52,000.00 |
| Mar 31, 2021 | 59,000.00 |
| Dec 31, 2020 | 71,000.00 |
| Sep 30, 2020 | 122,000.00 |
| Jun 30, 2020 | 638,000.00 |